Stricter compliance procedures eyed by Indian pharma

09/29/2013 | Business Standard (India)

Top Indian drugmakers say they need stricter compliance procedures and greater investment in quality to maintain their share in the global market amid concerns about increasing global enforcements. "Domestic companies represent a significant part of the global drug industry and, therefore, there is an increase in the scrutiny of these companies," Biocon Chairman and Managing Director Kiran Mazumdar-Shaw said. Audits are more frequent than earlier periodic reviews because of the U.S. FDA's presence in the country now, she said.

View Full Article in:

Business Standard (India)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID